# A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma

> **NCT06799676** · PHASE1,PHASE2 · NOT_YET_RECRUITING · sponsor: **Fuling Zhou** · enrollment: 42 (estimated)

## Conditions studied

- Newly Diagnosed Multiple Myeloma

## Interventions

- **DRUG:** a combination treatment of Linperlisib and the VRD regimen

## Key facts

- **NCT ID:** NCT06799676
- **Lead sponsor:** Fuling Zhou
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-02
- **Primary completion:** 2027-08
- **Final completion:** 2027-10
- **Target enrollment:** 42 (ESTIMATED)
- **Last updated:** 2025-01-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06799676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06799676, "A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06799676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*